Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New drug combo could ease painful mouth condition

NCT ID NCT07131813

First seen Jan 04, 2026 · Last updated May 23, 2026 · Updated 26 times

Summary

This study tests whether adding the drug tofacitinib to standard steroid treatment helps people with oral lichen planus, a chronic inflammatory mouth condition. About 60 adults with moderate to severe symptoms will receive either tofacitinib or a placebo pill alongside their usual steroid ointment for 12 weeks. The goal is to see if the combination reduces disease severity and pain more effectively than steroids alone.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ORAL LICHEN PLANUS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • AIIMS, Bhubaneswar

    RECRUITING

    Bhubaneswar, Odisha, 751019, India

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.